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higher scores for chronic inﬂammation compared to those
with dupA-negative strains (2.36 vs. 2.24, p = 0.058). The
presence of dupA was not associated with the cagA, vacA,
iceA or babA 2 genotypes.
Conclusions: In Shanghai the prevalence of dupA gene was
highest in DU and inversely related to GU and gastric cancer
both which are associated with corpus atrophy.
I-17 Antimicrobial susceptibility testing through
EUCAST
G. Kahlmeter1,2 *. 1Clinical Microbiology, Central Hospital,
Va¨xjo¨, Sweden, 2The European Committee on Antimicrobial
Susceptibility Testing (EUCAST), NONE
In order to categorise a bacterium as sensitive to
an antibiotic, it is necessary to perform a phenotypic
antimicrobial susceptibility test. Phenotypic AST systems
need breakpoints to. categorise bacteria S, I or R.
Breakpoints are best determined by breakpoint committees
consisting of experts in the ﬁelds of clinical microbiology
and infectious diseases. Both CLSI (formerly NCCLS
in the USA) and EUCAST (the European Committee
on Antimicrobial Susceptibility Testing) are well known
breakpoint committees. The former is a commercial
enterprise engaging the pharmaceutical industry and
the profession whereas the EUCAST is organised by
the European Centre for Disease Control, the European
Medicines Evaluation Agency and the European Society for
Clinical Microbiology and Infectious Diseases. EUCAST has
harmonised breakpoints for Europe and acts as the EMEA
breakpoint committee during the process of approval of
new drugs.
EUCAST breakpoints are currently being introduced in
automated systems for AST. The Phoenix from Becton
Dickinson is already validated with EUCAST breakpoints and
the Vitek2 from BioMerieux is to follow. A disk test based on
Mueller Hinton agar and 108 cfu/mL inoculum is currently
being developed by EUCAST.
New therapeutic traditions, dosage practices, new tools for
setting breakpoints and most importantly new resistance
mechanisms necessitates an evolutionary process for clinical
breakpoints. EUCAST has an active process for reviewing and
revising breakpoints.
EUCAST offers free documents on breakpoints, methods
and interpretive criteria on its website (www.eucast.org)
which also displays MIC- (and eventually zone diameter-)
distributions of wild type bacteria on the website. These
can be used for calibration of methods.
I-18 Laribacter hongkongensis: From discovery to
complete genome sequence
P.C.Y. Woo. Department of Microbiology, The University of
Hong Kong, Hong Kong, China
Despite extensive investigations, a microbiological cause
cannot be found in about half of the patients with infectious
disease. Throughout the years, scientists have spent
tremendous efforts in looking for microorganisms associated
with these “unexplained infectious disease syndromes”. In
2001, we discovered Laribacter hongkongensis gen. nov.
sp. nov., a facultative anaerobic, Gram-negative, S-shaped,
urease-positive rod of the Neisseriaceae family, from blood
and empyema thoracis of a patient with alcoholic cirrhosis.
During the past seven years, we have documented that
L. hongkongensis was associated with gastroenteritis and
traveler’s diarrhea and cases were found globally in patients
who resided in or had recent travel histories to countries
in Asia, Europe, America and Africa. We have found that
freshwater ﬁsh is the reservoir and it was also found
in drinking water reservoirs. We have cloned the beta-
lactamase and tetracycline resistance genes and developed
gene deletion and expression systems for L. hongkongensis.
Due to the potential of its clinical importance and
related ecology, important phenotypic characteristics and
phylogenetic position, and the availability of genetic
manipulation systems for downstream experiments, we
sequenced the complete genome of L. hongkongensis, with
the aim of achieving better understanding of its biology,
mechanism of adaptation to different hosts, and virulence
mechanisms.
I-19 Antibiotic resistance in gram-negative pathogens:
Dealing with untreatable infections
P.A. Tambyah*. National University of Singapore,
Singapore
While resistant gram-positive pathogens such as MRSA and
VRE have received a lot of attention especially in the US and
Europe, there have been rising numbers of multi-resistant
and even pan-drug resistant strains of gram-negative bacilli
in particular Pseudomonas and Acinetobacter spp. These
have posed tremendous challenges to the clinicians looking
after patients especially in Asia and Southern Europe. With
limited therapeutic options, a greater focus on prevention
and control has resulted. We are also hampered by a lack of
good data to explain the emergence of these pathogens and
to understand the reasons for their spread to our vulnerable
patients.
I-20 Two stage theory pathogenic mechanism of
Streptococcus suis
J. Xu, H. Zheng, C. Ye, H. Jing. State Key Laboratory
for Infectious Disease Prevention and Control, and
National Institute for Communicable Disease Control and
Prevention, China
Streptococcus suis infections are enzootic in pigs where
sporadic cases occur in humans. Since the ﬁrst human case
was recorded in 1968, only 250 cases have been reported
globally through June 2005. The majority of the cases have
resulted in meningitis often associated with hearing loss.
During the period from July to August 2005, however, an
explosive outbreak of 215 cases of human infection occurred
in Sichuan Province, China. Sixty-one of the 215 (28%)
patients presented an unusual streptococcal toxic shock
like syndrome (STSLS) with high mortality (38 of 61; 62%) in
previously healthy farmers. Both the clinical presentation
and epidemiology features of the Sichuan outbreak had not
previously been observed.
This outbreak was caused by a mutant S. suis named
as sequence type 7 (ST7) using the multi-locus sequence
typing method, the method of choice for addressing
questions related to genotyping for epidemiological studies,
population, and evolutionary biology. The ST7 strain caused
a single case described from Hong Kong in 1996; then it
emerged to cause a small outbreak in Jiangsu in 1998; and
spread to cause the largest ever outbreak with severe shock
in 2005.
It was found that the serum levels of IL-1b, IL-6, IL-8, IL-12,
p70, IFN-g and TNF-a, the inﬂammation cytokines, during
the early phase of the disease were signiﬁcantly elevated in
patients with STSLS compared to those with meningitis only.
And, the serum levels of pro-inﬂammatory cytokines were
signiﬁcantly higher in mice infected with the ST7 strain than
in those infected with either the ST1 or ST25 strains.
Genome comparisons showed the ST1 strain had acquired
132 genomic islands, including 5 pathogenicity islands, and
the “epidemic” strain ST7 had acquired an additional 5
genomic islands. Therefore, We proposed the intermediate
virulent ST25 type evolved to become the highly pathogenic
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ST1 type; and in-turn evolved recently to become the
“epidemic” ST7 type. The virulence increased in the ST7
type with its ability to stimulate massive amounts of pro-
inﬂammatory cytokines that led to the Streptococcal toxic
shock like syndrome.
Based on the information generated, we proposed a two
stage theory for the pathogenic mechanism of S. suis. When
the pathogen enters the human body (bloodstream), stage
one is initiated showing communication between bacterial
cell wall components with the host immune system using
pattern recognition receptors such as Toll-like receptor 2
and CD14; and probably by using the two-component signal
transduction system acquired recently with the consequent
burst of pro-inﬂammatory cytokines. The ST7 S. suis would
have mutated to stimulate the host to produce massive
amount of cytokines such as TNF-a, IL-1b and interferon
gamma that regulate high production levels of other
cytokines such as IL-6 and IL-12, leading to the STSLS. If a
patient survives the ﬁrst stage, the pathogen may reach the
central nervous system traveling free in the circulation or
monoctye-associated to cause the meningitis. The clinical
signiﬁcance of these ﬁndings was to prevent sudden death
associated with ST7 or ST1 S. suis infections where the
treatment was initiated early during the acute phase of the
infection, specially for therapies to prevent or reduce the
risk of STSLS.
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I-21 Prevalence of drug resistant HIV-1 in rural areas of
Hubei province in the People’s Republic of China
M.Q. Luo1, H. Liu1, K. Zhuang1, L. Liu3, B. Su1, R.R. Yang2,
P. Tien1, L.Q. Zhang4, X. Gui2, Z.W. Chen3 *. 1Modern
Virology Research Center and AIDS Center, State Key
Laboratory of Virology, College of Life Sciences, Wuhan
University, Hubei 430072, P.R. China, 2Zhongnan Hospital,
Wuhan University, Wuhan 430072, China, 3AIDS Institute,
The University of Hong Kong Li Ka Shing Faculty of
Medicine, Hong Kong SAR, China, 4AIDS Research Center,
Chinese Academy of Medical Sciences Peking Union Medical
College, Beijing 100730, China
Objective: To determine the prevalence of drug resistant
HIV-1 and the efﬁcacy of ﬁrst-line HAART regimens consisting
of generic NRTI and NNRTI among 339 study subjects in rural
areas of Hubei province, China.
Methods: Two cross-sectional studies were conducted
to investigate 150 HAART-naive (99 received subsequent
therapy) between 2003 and 2005 and 288 HAART-
experienced patients between 2006 and 2007. Patients’
CD4+ T-cell count and viral load were determined. HIV-1
pol gene fragments were ampliﬁed from patients’ plasma
by RT-PCR, subsequently sequenced and analyzed.
Results: 83.5% of the patients were from rural villages.
They were dominantly infected with subtype B′ HIV-1
(97.4%) through paid blood donation (64.6%) and related
blood transfusion (28.3%). We found that there was a
steady increase of CD4 count over time among treated
patients without detectable viral load (186/288, 64.6%).
There was, however, an increasing prevalence of NRTI and
NNRTI resistant mutations among patients with detected
viremia (102/288, 35.4%) after treatment for 3 6 (24.3%),
9 12 (57.1%) and 20 24 (63.3%) months, respectively. The
increasing rates were associated with signiﬁcant CD4 count
drop and viral load increase. Some patients also developed
multi-drug resistant mutants.
Conclusions: We report the ﬁrst HIV-1 drug resistance study
after two-years on HAART among Chinese patients living in
rural villages. Our data suggest that a signiﬁcant portion
of patients are failing ﬁrst-line regimens with a trend of
AIDS progression. It is therefore necessary to maximize
the drug adherence and to make affordable second-line
HAART regimens available immediately. Our results have
implications for implementing HAART in under-resourced
developing country settings.
I-22 Molecular epidemiology of drug resistant HIV-1 in
Hong Kong
W.C. Yam*. Department of Microbiology, The University of
Hong Kong, China
The combination antiretroviral therapy is referred as
Highly Active Antiretroviral Therapy (HAART) which inhibits
different pathways of HIV pathogenesis so that viral
replication can be effectively suppressed. Following the
introduction of HAART since late 90s, signiﬁcant decline in
morbidity, mortality and HIV/AIDS incidence was reported
in Hong Kong. To monitor the efﬁcacy of HAART, genotyping
resistance test (GRT) by PCR-sequencing of the viral pol
gene (PR codon 1 to RT codon 410) was used to study 1,015
samples collected from 830 HIV-1+ patients. Results showed
good concordance to clinical response among treatment
experienced patients. Primary resistance was detected
among 6.7% of the treatment naive samples and GRT also
revealed the predominant subtypes CRF01_AE (45.8%) and
B (41.2%) were followed by C (4.4%), CRF07_BC (1.7%),
A1 (1.3%), CRF08_BC (0.9%), CRF02_AG (0.6%), CRF06_cpx
(0.3%) and G (0.1%). Mutations D30N, G48V and I84V were
only detected in subtype B while V32I mutation was only
detected in CRF01_AE. Resistance associated with HAART
were detected among 10% treatment experienced patients
after 18 24 months on HAART in Hong Kong. Increasing
prevalence of the primary resistance in Hong Kong was
detected since 1997 without subtype preference. The
presence of primary resistance in treatment naive patients
indicates the need for GRT on pre- and post-treatment
samples, so that appropriate regimens for HAART can be
implemented. Phylogenetic analysis of the pol gene also
identiﬁed 3 major local clusters of CRF01_AE subtypes
and B subtypes which were clonally related to reference
sequences from major cities in China (Fujian, Pingxiang and
Nanning).
I-23 Opportunistic infections in AIDS: Thai experience
B. Sathapatayavongs *. Department of Medicine, Faculty
of Medicine Ramathibodi Hospital, Mahidol University,
Bangkok, Thailand
The ﬁrst Thai AIDS case was imported in 1984, since then
approximately one million Thais have been infected with
HIV, and currently, the estimated prevalence of HIV infection
is about 1%. There were 5 consecutive epidemic waves
as follows: among male homosexuals (started 1985), rapid
surge in intravenous drug users (1988), followed by female
commercial sex workers (1989), their male clients (1990)
and lastly wives and newborn of the latter (1991). Most
HIV infection is transmitted via heterosexual activities. This
spreading of infection occurred rapidly and caused great
alarm to all people involved.
Fortunately, the Thai Government at that time has
recognized this problem and considered AIDS prevention
and control a high national priority, involving several
ministries: Education, Health, Interior, etc. Thailand has
successfully slowed down the epidemic. However, hundred
thousands of people have already been infected. Prior to
the HAART era, hundreds of HIV-infected people became ill
with opportunistic infections (OI) and hence the diagnosis
of AIDS with high mortality. From our experience during
